Engagement with Compounding Outsourcing Facilities

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
FDA-RFP-1223623
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring MD 20993 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration seeks to establish a Center of Excellence to provide engagement and training to compounding outsourcing facilities. Support services are solicited to conduct virtual and in-person trainings, develop web-based educational modules, host an annual conference, and assist in establishing the Center's strategic plan. Proposals will be evaluated on technical approach, past performance, and price, with award made to a single contractor. Questions are due by July 29, 2020 and proposals by August 21, 2020.

There is no set-aside designation. The NAICS code is 541611 and PSC code R425. The period of performance is a 12-month base year and four 12-month option years under a time and materials contract to be administered by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services, with work to be performed in Silver Spring, Maryland. Estimated labor hours and fully burdened rates must be proposed.

Notice text

2 versions

Update #2 · Latest ·

AMENDMENT 1 to FDA-RFP-1223623 (Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities)

The purpose of Amendment 1 to FDA-RFP-1223623 is to post FDA responses to timely vendor questions received for this solicitation. Amendment 1 includes an "FDA Responses to Vendor Questions" document, an Amendment 1 revision to the solicitation document and an Amendment 1 revision to the Statement of Work. All revised documents are attached and changes are highlighted in yellow throughout the documents. Please refer to the solicitation Amendment 1 documents for further information.

Update #1 ·

FDA-RFP-1223623 (Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities)

The purpose of FDA-RFP-1223623 is to acquire support services for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities. Please refer to the solicitation document and all attachments for further information.

Files

File Type Posted
FDA RESPONSES TO VENDOR QUESTIONS-FDA-RFP-1223623.pdf PDF
Sol_Doc_1223623_Amendment_1.pdf PDF
Attachment 1_SOW_Amendment 1 Rev.pdf PDF
Sol Doc_A1_SOW_1223623.pdf PDF
Sol_Doc_A3_Subcontract Plan_1223623.doc DOC document
Sol_Doc_A2_RFP_QT_1223623.docx DOCX document
Sol_Doc_1223623.pdf PDF

Notice history

Notice Type Posted
Engagement with Compounding Outsourcing Facilities Award Award Notice
This notice Latest solicitation Solicitation
Engagement with Compounding Outsourcing Facilities Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity